Joseph C Longenecker
Affiliation: Johns Hopkins Bloomberg School of Public Health
- Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE StudyJ Craig Longenecker
Johns Hopkins University School of Medicine, Suite 2 637, 2024 E Monument Street, Baltimore, MD 21205, USA
J Am Soc Nephrol 13:1918-27. 2002..In summary, many ASCVD risk factors are more prevalent in ESRD than in the general population and may explain some, but probably not all, of the increased ASCVD risk in ESRD...
- Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE studyJ Craig Longenecker
Johns Hopkins University, Baltimore, MD 21205, USA
Circulation 106:2812-8. 2002..Previous studies suggest that high Lp(a) levels and small apolipoprotein(a) [apo(a)] isoform size are associated with ASCVD, but none have investigated the relationship between Lp(a) level, apo(a) size, and mortality...
- Association of kidney function with serum lipoprotein(a) level: the third National Health and Nutrition Examination Survey (1991-1994)Csaba P Kovesdy
Division of Renal Medicine, Salem Veterans Affairs Medical Center, Salem, VA 24153, USA
Am J Kidney Dis 40:899-908. 2002..Elevated lipoprotein(a) (Lp[a]) levels have been observed in patients on dialysis therapy. However, few studies explored the relationship between kidney function and Lp(a) levels in patients with mild to moderate chronic kidney disease...